Serum Neopterin Is Not Increased in Obese Juveniles

被引:6
|
作者
Mangge, Harald [1 ]
Freytag, Florian [1 ]
Almer, Gunter [1 ]
Weghuber, Daniel [2 ]
Bauer-Denk, Carmen [1 ]
Fuchs, Dietmar [3 ]
机构
[1] Med Univ Graz, Clin Inst Med & Chem Lab Diagnost, A-8036 Graz, Austria
[2] Univ Hosp Salzburg, Dept Pediat, A-5020 Salzburg, Austria
[3] Med Univ Innsbruck, Div Biol Chem Bioctr, A-6020 Innsbruck, Austria
关键词
D O I
10.1155/2011/946795
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. Cardiovascular disease is associated with inflammation and immune activation, concentrations of immune activation markers like neopterin predict outcome in adults. Methods. Serum neopterin concentrations and early metabolic and pre-atherosclerotic symptoms were analyzed in 295 obese juveniles and 101 normal weight controls of similar age. Additionally, the influence of a 12 months weight reduction program on neopterin levels was investigated in 31 obese juveniles. Results. Intima-media thickness of common carotid arteries (IMT) and the concentrations of C-reactive protein (CRP) were increased in the obese juveniles (P < .001). Also triglycerides, oxidized LDL, fasted insulin levels, HOMA-index, leptin, liver transaminases and uric acid were increased compared to the controls. However, serum neopterin was decreased in the obese versus non-obese juveniles (P < .03). The intervention consisting of regular sports, nutritional devices, and a psychologic attendance led after 12 months to an increase of neopterin concentration (P < .05; paired test). Conclusions. Neopterin concentrations in juvenile obesity behaved considerably different from what was demonstrated in adults, levels did not correlate with metabolic and pre-atherosclerotic symptoms found in early phases although early vascular burden and chronic low grade inflammation was indicated by increased IMT and CRP. Neopterin concentrations increased after a 12 months intervention program.
引用
收藏
页数:7
相关论文
共 50 条
  • [21] SERUM NEOPTERIN IN DILATED CARDIOMYOPATHY
    NASONOV, YL
    SAMSONOV, MY
    MASENKO, VP
    ALEXANDROVA, LZ
    KOSTIN, SI
    SAMKO, AN
    NAUMOV, VG
    TERAPEVTICHESKII ARKHIV, 1990, 62 (04) : 72 - 75
  • [22] NEOPTERIN DETERMINATION IN SERUM WITH HPLC
    REIBNEGGER, G
    FUCHS, D
    HAUSEN, A
    HUBER, JFK
    LANG, HRM
    WERNER, E
    WACHTER, H
    HOPPE-SEYLERS ZEITSCHRIFT FUR PHYSIOLOGISCHE CHEMIE, 1984, 365 (09): : 942 - 943
  • [23] DETERMINATION OF NEOPTERIN IN SERUM AND URINE
    WERNER, ER
    BICHLER, A
    DAXENBICHLER, G
    FUCHS, D
    FUITH, LC
    HAUSEN, A
    HETZEL, H
    REIBNEGGER, G
    WACHTER, H
    CLINICAL CHEMISTRY, 1987, 33 (01) : 62 - 66
  • [24] Clinical evaluation of serum neopterin
    Ogi, M
    CLINICAL CHEMISTRY, 1996, 42 (06) : 607 - 607
  • [25] Increased serum and urinary neopterin in nephrotic syndrome indicate cell-mediated immune dysfunction
    Oda, K
    Arai, T
    Nagase, M
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1999, 34 (04) : 611 - 617
  • [26] Increased serum levels of neopterin and soluble interleukin-2 receptor in intrahepatic cholestasis of pregnancy
    Wang, ZP
    Dong, MY
    Chu, HN
    He, J
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2004, 83 (11) : 1067 - 1070
  • [27] INCREASED URINE NEOPTERIN LEVELS IN PSORIASIS
    HARLAND, CC
    WHITAKER, RP
    BARRON, JL
    HOLDEN, CA
    BRITISH JOURNAL OF DERMATOLOGY, 1992, 127 (05) : 453 - 457
  • [28] Elevated serum neopterin and homocysteine increased the risk of ischemic stroke in patients with transient ischemic attack
    Xie, Jing
    Qiu, Xiandi
    Ji, Chunli
    Liu, Chunhong
    Wu, Yueming
    PTERIDINES, 2019, 30 (01) : 59 - 64
  • [29] INCREASED SERUM NEOPTERIN CONCENTRATION AS INDICATOR OF DISEASE SEVERITY AND POOR SURVIVAL IN MULTIPLE-MYELOMA
    BOCCADORO, M
    BATTAGLIO, S
    OMEDE, P
    PALUMBO, AP
    FUSARO, A
    FRIERI, R
    GALLONE, G
    POLLONI, R
    MOSSO, R
    DEFILIPPI, P
    PILERI, A
    EUROPEAN JOURNAL OF HAEMATOLOGY, 1991, 47 (04) : 305 - 309
  • [30] INCREASED CONCENTRATIONS OF NEOPTERIN IN CAROTID ATHEROSCLEROSIS
    WEISS, G
    WILLEIT, J
    KIECHL, S
    FUCHS, D
    JAROSCH, E
    OBERHOLLENZER, F
    REIBNEGGER, G
    TILZ, GP
    GERSTENBRAND, F
    WACHTER, H
    ATHEROSCLEROSIS, 1994, 106 (02) : 263 - 271